Bigul

PANACEA BIOTEC LTD. - 531349 - Intimation Of The 38Th Annual General Meeting Of Panacea Biotec Limited ('The Company') For The Financial Year 2021-22 And Details Of Book Closure, Cut-Off Date For E-Voting And E-Voting Period

We would like to inform you that 38th AGM of the Company is to be held on Wednesday, 28.09.2022 at 11:30 A.M. through VC / OAVM. A copy of Notice of AGM along with Annual Report for FY 2021-22 sent to the shareholders through email is enclosed herewith for your reference. Also, the Company is pleased to provide remote e-voting facility to its members to cast their votes electronically on all resolutions set forth in enclosed AGM Notice. Further, relating to AGM of the Company, you are requested to take note of the following: 1. Register of Members and Share Transfer Books shall remain closed from 21.09.2022 to 28.09.2022 (both days inclusive). 2. The cut-off date for remote e-voting, shall be 21.09.2022. 3. The remote e-voting period shall commence on 25.09. 2022 (from 09:00 a.m. IST) and end on 27.09.2022 (upto 05:00 p.m. IST). Remote e-Voting facility will also be available during the AGM for the members attending the AGM. This is for your kind information and record please.
06-09-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulations 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the public notice, requesting shareholders to register their email addresses with the Company in connection with the ensuing 38th Annual General Meeting of the Company scheduled to be held on Wednesday, September 28, 2022 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means as published on August 26, 2022 in the following newspapers:- Business Standard - All Editions; and Desh Sewak - Punjabi Edition This is for your kind information and record please.
27-08-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In continuation to our letter dated August 09, 2022 for approving the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company for the Quarter ended June 30, 2022 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the Extract of Statement of aforesaid Unaudited Financial Results published in the following newspapers on August 10,2022:- Business Standard (English); Desh Sewak (Punjabi)
10-08-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2022

The Board of Directors of the Company has, at its meeting held today, i.e. August 09, 2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on August 09, 2022. A copy of the same along with the Limited Review Report is enclosed herewith as Annexure - A. The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 3:15 P.M.
09-08-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Outcome for I. Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2022 Ii. Date, Time And Venue Of The 38Th AGM Iii. Dates Of Book Closure

The Board of Directors of the Company has, at its meeting held on 09.08.2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) for the quarter ended June 30, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on 09.08.2022. We wish to further inform you that the Board of Directors has also decided that: i) the 38th AGM of the Company will be held on Wednesday, 28.09.2022 at 11:30 A.M. through VC / Other Audio-Visual Means; and ii) the Register of Members and Share Transfer Books will remain closed from Wednesday, 21.09.2022 to Wednesday, 28.09.2022 (both days inclusive) for the purpose of AGM. The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 3:15 P.M.
09-08-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

This is with reference to CDSL''s Operating Instructions for Issuers/RTAs, which states that the Issuer / RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of July, 2022
07-08-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for For Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30, 2022

PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30, 2022. Further, with reference to our earlier announcement dated June 28, 2022 intimating the Closure of Trading Window pursuant to the Company''s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company and Material Subsidiary of the Company till August 11, 2022 and the same will re-open from August 12, 2022.
27-07-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Statement Of Investor Complaints For The Quarter Ended June 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vinod GoelDesignation :- Company Secretary and Compliance Officer
21-07-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are enclosing herewith a certificate dated July 02, 2022, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2022.
05-07-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of June, 2022.
05-07-2022
Next Page
Close

Let's Open Free Demat Account